Argus retinal prosthesis | 合法醫療器材資訊網

TheArgusIIisspecificallydesignedtotreatpeoplewithretinitispigmentosa....Thedevicewasapprovedwithdatafromasingle-armclinicaltrialthatenrolledthirty ...

Argus retinal prosthesis, also known as a bionic eye, is an electronic retinal implant manufactured by the American company Second Sight Medical Products. It is used as a visual prosthesis to improve the vision of people with severe cases of retinitis pigmentosa. The Argus II version of the system was approved for marketing in the European Union in March 2011, and it received approval in the US in February 2013 under a humanitarian device exemption. The Argus II system costs about US$150,000, excluding the cost of the implantation surgery and training to learn to use the device. Second Sight had its IPO in 2014 and was listed on Nasdaq.[1]

Production and development of the prosthesis was discontinued in 2020,[2] but taken over by the company Cortigent in 2023.[3]

The Argus II is specific...